For millions of Portuguese people, a cup of coffee is a daily ritual. Can this deeply ingrained habit play a role in the prevention, treatment or survival of breast cancer? 

The agreement between the two organisations will enable the reinforcement of the Breast Cancer Research Program (BCRP) from the Breast Department to launch a pioneering line of research in Portugal. This line of research is entirely funded by Delta Cafés, which is thus playing an active role in advancing scientific knowledge.

The Vision Award Office is where ideas are shaped into global recognition.

It is here that the António Champalimaud Vision Award takes form, through careful preparation, collaboration and informed decision-making.

It is also home to the Ethics Committee, where research projects, in particular clinical studies, are supported and rigorously reviewed.

Here, decisions are not rushed. They are considered, debated and refined.

Because creating impact, and recognising it, requires the freedom to think deeply, to question, and to choose with responsibility.

Under the central theme of efficiency as a condition for a more sustainable, equitable and future-ready healthcare system, the event established itself as a forum for discussing concrete solutions, with proposals for more efficient use of public investment, improved incentives for professionals and patient-centred policies.

Caring for patients is one of the Champalimaud Foundation’s core purposes, and the Radiotherapy Service supports that mission every day. 

In a highly controlled environment, precise doses of radiation are targeted to treat different types of cancer. 

Behind this precision is a dedicated team of specialised doctors, physicists, nurses and technicians, working together to ensure each treatment is both safe and effective.

Every detail matters. Every decision is guided by expertise, responsibility and care.

Based at the Champalimaud Foundation’s Neuropsychiatry Unit and the newly established Digital Neurotherapeutics Centre, Cotovio is recognised for research that advances a more mechanistic understanding of psychiatric disorders. As part of this distinction, he is featured in the Innovators & Ideas series in Brain Medicine, which highlights emerging leaders in translational neuroscience.
 

Towards causal models in psychiatry

Host

Carlos Minutti, PhD, Immunoregulation Lab

Venue

Seminar Room

A synergy in advanced therapies

Signed in Rome on 28 April, the agreement combines the Champalimaud Foundation’s expertise in adult oncology with Bambino Gesù’s recognised leadership in paediatric oncology and cell therapies. This synergy strengthens the link between research and clinical practice throughout the translational medicine pathway.

The Teaching Lab is much more than a classroom. It’s where students, from their first experiments to their PhDs, develop the confidence to ask questions and test ideas.

Used daily by researchers and students alike, this space is a hub for building and refining scientific setups, and a venue for workshops and courses that welcome new minds every year.

It has reshaped how science is done at the Champalimaud Foundation. By empowering students, it strengthens entire research teams.

This was the starting point for RTP’s programme Hora de Agir, which dedicated one of its episodes to carbon neutrality in healthcare, highlighting the path the Champalimaud Foundation is taking to become the first healthcare institution in the world to operate on 100% clean energy. The programme featured João Silveira Botelho, Vice-President of the Champalimaud Foundation, who stressed the urgency of transforming how healthcare consumes energy and resources.